{"id":79585,"sourceType":"web_search","title":"Milwaukee Courier, quoting Democratic Health Committee members","url":null,"publication":"Directed Inquiry — Web Search","date":null,"entity":{"id":163001,"name":"One Big Beautiful Bill","slug":"one-big-beautiful-bill"},"custody":{"contentHash":"3914a3574334cdb0a13ddcd31863cf2c43cc4b02784fdedbf08611ab4f9ebfe0","contentHashAt":"2026-10-01T09:07:35.589Z","contentLength":178,"capturedAt":"2026-10-01T09:07:35.589Z","hashAlgorithm":"sha256","hashFormula":"sha256(coalesce(url, '<no-url>') || '\\n' || raw_content)","hashEncoding":"hex"},"mediaCitation":null,"preview":"The One Big Beautiful Bill weakened Medicare's ability to negotiate the price of drugs with 'orphan drug designation,' including cancer treatments Darzalex, Keytruda, and Opdivo.","verifyUrl":"/source/79585/verify","htmlReceiptUrl":"/source/79585/receipt","corpusAttestationUrl":"/attestation/latest.json"}